SpecialIssueSpectral-DomainOpticalCoherenceTomographyFindingsinNeuroﬁbromatosisType2VanessaWaisberg,1LuizOswaldoCarneiroRodrigues,2M´arcioBittarNehemy,1MariaFrasson,1andD´eboraMarquesdeMiranda31DepartmentofOphthalmology,ClinicalHospitalofFederalUniversityofMinasGerais,BeloHorizonte(MG),Brazil2DepartmentofClinicalMedicineandNeuroﬁbromatosisReferenceCenter,ClinicalHospitalofFederalUniversityofMinasGerais,BeloHorizonte(MG),Brazil3DepartmentofPediatricsandINCTMolecularMedicine,ClinicalHospitalofFederalUniversityofMinasGerais,BeloHorizonte(MG),BrazilCorrespondence:VanessaWaisberg,AvenidaBrasil,691/401,BeloHori-zonte,MG,30140-000,Brazil;vanessawaisberg@hotmail.com.Submitted:December14,2015Accepted:May14,2016Citation:WaisbergV,RodriguesLOC,NehemyMB,FrassonM,deMirandaDM.Spectral-domainopticalcoher-encetomographyﬁndingsinneuroﬁ-bromatosistype2.InvestOphthalmolVisSci.2016;57:OCT262–OCT267.DOI:10.1167/iovs.15-18919PURPOSE.Neuroﬁbromatosistype2(NF2)isanautosomal-dominantdisease,characterizedbybilateralvestibularschwannomas,multiplecentralnervoussystem(CNS)tumors,skintumors,andjuvenilecataract.Thepresentstudyassessedretinalabnormalitiesusingspectral-domainopticalcoherencetomography(SD-OCT)inacaseseriesofNF2patients.METHODS.NineNF2patientsfromtheneuroﬁbromatosisoutpatientreferencecenteroftheFederalUniversityofMinasGerais,inBrazil,weresubmittedtoacompleteanamnesisandadetailedophthalmicevaluation,includingSD-OCT,todetectretinallesions.RESULTS.OfthenineNF2patientsevaluated,ﬁvehadanearlyonset(<20years)ofNF2,andfourpatientshadalateonset(>20years)ofsymptoms.SD-OCTscansrevealedretinalabnormalitiesineverypatientwithearlyonset(EOS)andintwopatientswithlateonset(LOS)ofthedisease.IntheEOSgroup,SD-OCTscansrevealedﬂame-shapedepiretinalmembranes(ERM)withpeculiarcharacteristicsinfoureyesofthreepatients.TwopatientshadﬁneundulationsoftheinnerretinalsurfacewithasubtleERM.RetinalhamartomaswerepresentinfoureyesofthreepatientswithEOS;intwoeyes,theyweresubclinicalandweredetectedonlybySD-OCTscans.IntwopatientswithLOSandonepatientwithEOS,SD-OCTscansrevealedretinaltuftsofanerveﬁberlayer.CONCLUSIONS.SD-OCTrevealedERMinmostpatientswithNF2,thereforeitmaybeavaluableexamforevaluatingNF2patients.EpiretinalmembranesinNF2hasuniquefeatures,distinguishingitfromidiopathicERMormembranesassociatedwithotherdiseases.Wesuggestthatﬂame-shapedERMseemstobespeciﬁcforNF2andthatERMcanbeconsideredasanimportantdiagnosticsignofNF2.Keywords:neuroﬁbromatosistype2,opticalcoherencetomography,retina,vestibularschwannoma,epiretinalmembraneNeuroﬁbromatosiscomprisesatleastthreedistinctdisorderscausedbymutationsindifferentgenes1asfollows:neuroﬁbromatosis1(NF1)iscausedbymutationsthatinactivatetheneuroﬁbromingeneonchromosome17q2;neuroﬁbromatosis2(NF2)iscausedbyinactivatingmutationsofthemerlingeneonchromosome22q3,4;andSchwannoma-tosis,iscausedbygermlinemutationsintheSMARCB1(orINI1)gene.5Neuroﬁbromatosis2isanautosomal-dominantdisease,whichischaracterizedbybilateralvestibularschwannomas,multiplecentralnervoussystem(CNS)tumors,skintumors,andjuvenilecataract.6,7Itsestimatedincidenceliesbetween1in33,0008livebirthsand1in87,410livebirths.9Thefollowingtwoclinicalsubtypeshavebeenproposed:(1)theseveresubtype,orWishartsubtype,whichusuallypresentsanageonsetatapproximately20andareseentoenhanceCNStumorsformationsinadditiontobilateralvestibularschwan-noma,exhibitingrapidclinicalprogression,7,10,11and(2)themildsubtype,orGardnersubtype,whichoftenlackssymptomswithinthethirddecadeofthepatient’slife,andpresentswithfewtumorsotherthanvestibularschwannoma,whichhasarelativelybenignclinicalcourse.7,10,12AlthoughNF2isinheritedinanautosomal-dominantmanner,approximatelyhalfofthecasesinaffectedindividualsarecausedbysporadicmutation,andthereisahighrateofmosaicism.13,14Awell-deﬁnedspectrumofocularfeaturesisassociatedwithNF2.OcularabnormalitiesassociatedwithNF2areposteriorsubcapsular/capsularorcorticallenticularopacities,RPEhamartomas,retinalhamartomas,epiretinalmembranes(ERM),paralyticstrabismus,andopticnervesheathmeningi-omas.15–17Opticalcoherencetomography(OCT)isanoninvasivediagnostictechniquethatrendersaninvivocross-sectionalviewoftheretina.SD-OCTtechnologyusesinfraredlighttoproduceimagesoftheretinawithveryhighresolution(<7lm).Opticalcoherencetomographyandnear-infraredreﬂec-tance(NIR)havebeenshowntobevaluabletoolstoevaluateNF1patients.ChoroidalnodulesdetectedbyNIRandSD-OCThavehighspeciﬁcityasdiagnosticindicatorsofNF1.18,19iovs.arvojournals.orgjISSN:1552-5783OCT262ThisworkislicensedunderaCreativeCommonsAttribution-NonCommercial-NoDerivatives4.0InternationalLicense.Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935468/ on 06/25/2017EvaluationofperipapillaryRNFLthicknesshasbeenproposedasanoninvasivetestingmethodtodetectearlysignsofopticpathwaygliomasinchildrenwithNF1.20,21ThereislittleinformationaboutOCTinNF2,probablybecauseNF2ismuchrarerthanNF1.Thereshouldbemorestudiesontheprevalence,signiﬁcance,relevance,andimpactofophthalmo-logicﬁndingsonNF2.Epiretinalmembranesisasemitranslu-cent,avascular,ﬁbrocellularmembraneontheinnerretinalsurfacethatiscausedbyproliferatingchangesatthevitreoretinalinterface.Epiretinalmembranescanbeidiopathicorsecondarytoawidevarietyofintraocularconditions.IdiopathicERMismostcommoninpatientsovertheageofﬁfty.EpiretinalmembraneshavebeendescribedasanNF2ocularﬁndingsince1992,anditsincidencevariesamongauthorsfrom30%to80%.15,16,22–24Sisk25associatedERMwithaseverephenotypeofNF2.ThegoldstandardexamfordiagnosingandanalyzingERMisSD-OCT.Scheﬂer26describedOCTcharacteristicsofERMinthreepatientswithNF2.ThisdescriptionreportedanERMwithuniquefeatures,whichweredescribedasseveralcelllayersthickwithcurlededgesstretchingintothevitreoretinalinterface.ConsideringthatSD-OCTisanoninvasiveandeasilyperformedexam,thepresentstudyaimstoevaluateretinalabnormalitiesusingSD-OCTinagroupofNF2patientstocharacterizethefrequencyandrelevanceofERMforNF2.METHODSPatientsBetweenFebruary2014andJune2015,weevaluatedninepatientswithNF2.PatientswereclinicallyexaminedinaneuroﬁbromatosisoutpatientreferencecenteroftheFederalUniversityofMinasGerais,BeloHorizonte,Brazil.TheNF2diagnosiswasconﬁrmedbyneuroimaging.NoneofthenineNF2patientswereparentallyrelated.Nineage-andsex-matchingcontrolswithnohistoryofneurologicorophthal-mologicdisorderswereincluded.Eyeexaminationwasperformedin18NF2eyes,anditincludedmeasurementofthevisualacuityandbiomicroscopybeforeandafterpupillarydilatation,withspecialattentiontothepresenceofirishamartomasandlensopacities,dilatedfundusexamination,colorfundusphotography,infraredphotography,fundusautoﬂuorescence,andSD-OCT.SD-OCTwasaccomplishedin17NF2eyes;inoneeye,OCTscanswerenotperformed,duetoadensesubcapsularlensopacity.OpticalcoherencetomographyexaminationswereperformedbymeansofSpectralisHRAþOCT(HeidelbergEyeExplorerVersion1.9.10.0–AcquisitionSoftwareVersion:6.0.11.0;HeidelbergEngineering,Heidelberg,Germany).Acquisitionprotocolsincludedatleastonecross-hairscan,a208315819B-scansmacularcube,a208315819B-scansmacularcubewithenhanced-depthimaging(EDI)andmodewithadditionalhorizontalandverticalsinglelinesorcube,tocoveranylesiondetectedbyclinicalexaminationorfundusphotography.ThestudywasapprovedbytheethicscommitteeoftheClinicalHospitaloftheFederalUniversityofMinasGeraisandfollowedtheprinciplesoftheDeclarationofHelsinki.OCTImageAnalysisTwotrainedophthalmologistsindependentlyanalyzedtheimagesforqualitativeOCTvariables,andquantitativemea-surementsofanatomicalfeaturesandaseniormaskedinvestigatorprovidedarbitrationincasesofdisagreement.TheimageswereevaluatedforthepresenceofERM,typeofERM,presenceofvitreousmacularadhesion(VMA),fovealdeformation,retinalfoldsorundulations,internallimitingmembrane(ILM)disruption,ellipsoidzonedisruption(EZD),centralmacularthickness(CMT),andretinalnerveﬁberlayer(RNFL)thickness.Theinnercircleof1-mmradiusofEarlyTreatmentDiabeticRetinopathyStudymapwasdeﬁnedasCMT.RESULTSDemographicsDemographicdataareshowninTable1.TheoveralldelaybetweentheonsetofsymptomsanddiagnosisofNF2averaged6.7years.Oftheninepatients,ﬁvehadanearlyonset(EOS)ofNF2(<20years),andthedelaybetweentheﬁrstsymptomsanddiagnosisinthisgroupwasanaverageof7.8years(range,1–18years;Table1).Theinitialsymptomsoftheseﬁvepatientswereunspeciﬁcsymptoms,suchasconvulsion,strabismus,chestpain,inferiorlimbparesis,andcaf´eaulaitspots.Lateonset(LOS)ofNF2(>20years)wasobservedinfourofninepatients,andthedelaybetweentheﬁrstsymptomsanddiagnosisaveraged5.5years(range,0–14years).Theinitialsymptomsofthesefourpatientswerealsounspeciﬁc,includinginferiorlimbsparesis,facialpalsy,facialpain,andcervicalpain.SpeciﬁcNF2OcularFindingsNeuroﬁbromatosis2-speciﬁcocularﬁndingswereobservedineightofninepatients,allﬁvepatientsintheEOSgroup,andthreeintheLOSgroup.Cataractswerenotedinﬁveofninepatients(3withEOSand2withLOS).Cataractswerevisuallyimpactingfoureyesofthreepatients.OnepatientintheEOSgrouphadchronic-appearingretinaldetachmentandretinalhamartomaintherighteye.EpiretinalmembraneswerenotedinallﬁvepatientsintheEOSgroup;threepatientshadthickERMwithpeculiarcharacteristicsonSD-OCTscans,andtwopatientshadsubtleERMwithﬁneundulationsontheinnerretinalsurface.RetinalhamartomaswerenotedinfoureyesofthreepatientsintheEOSgroup.Inbotheyesofpatientsevenretinalhamartomasweresubclinical,detectedonlybySD-OCT.Allpatientswithepiretinalmembraneandretinalhamartomawereintheearlyonsetgroup.TwopatientswithLOShadsubtleretinalabnormalitiesthatweredetectedexclusivelybySD-OCT;theseabnormalitiesweresmallelevationsofRNFLthatwerecompatiblewithRNFLtufts.StrabismuswasnotedintwopatientsintheEOSgroup.PatientswithanearlyonsethadmoreNF2-speciﬁcocularﬁndings(Table2).TABLE1.PatientDemographicsPatientN8SexSymptomDuration,yAgeatLastVisit,yDelayinDiagnosis,y1M35002F33303*M202884*M1719155*M81436F1237127*F163218*F62419F214814*Patientswithearlyonset.SD-OCTFindingsinNeurofibromatosisType2IOVSjSpecialIssuejVol.57jNo.9jOCT263Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935468/ on 06/25/2017OtherOphthalmologicFindingsNonspeciﬁcophthalmologicﬁndingsweredetectedinfourpatients.Exposurekeratopathywasfoundinthreepatients(2withEOSand1withLOS),carunculanevusinonepatientintheLOSgroup,opticdiscedemainthreeeyesoftwopatientsintheEOSgroup,andopticnerveatrophyinoneeyeofapatientintheEOSgroup.OpticalCoherenceTomographyQuantitativeAnalysis.Themeancentralmacularthick-ness(CMT)was269635lmincontroleyesand311683lminallNF2eyes.IntheEOSeyes,CMTwas3526101lm;intheLOSeyes,CMTwas268617lm.Thetotalmacularvolume(TMV)was8.79þ 0.18mm3incontroleyesand8.66þ 0.78mm3inallNF2eyes.IntheEOSeyes,theTMVwas8.68þ 1.12mm3;intheLOSeyes,theTMVwas8.64þ 0.24mm3.TheSDshowsgreatvariabilityinthethicknessandvolumemeasurementsintheEOSeyes(Table3).ThemeanperipapillaryRNFLthicknessinEOSpatientswas153þ 104lminthesuperiorsector,97þ 77lminthenasalsector,170þ 125lmintheinferiorsectorand64þ 18lminthetemporalsector.InLOSpatientsthemeanperipapillaryRNFLthicknesswas144þ 14lminthesuperiorsector,70þ 13lminthenasalsector,139þ 12lmintheinferiorsectorand75þ 8lminthetemporalsector.ThegreatvariabilityinperipapillarythicknessobservedinEOSgroupwasrelatedtoopticnerveatrophyinoneeyeandopticdiscedemaintreeeyes.QualitativeAnalysis.SD-OCTscansrevealedretinalabnormalitiesinallpatientswithEOSandintwopatientswithLOS.AthickanddenseERMatthemacula,withaﬂame-shapedappearanceextendingintothevitreous,wasobservedinfoureyesofthreepatientswithEOS(Fig.1).Inthreeeyeswithaﬂame-shapedERM,therewaslossoffovealcontour.TheseERMswerenotvisuallysigniﬁcant,despitethemarkedretinalthickeningandfovealdeformation.UndulationsoftheinnerretinalsurfacewithasubtleERMwereobservedinthreeeyesoftwopatientswithEOS(Fig.2).IntwoeyesoftwopatientswithLOSandoneeyeofapatientwithEOS,SD-OCTscansrevealedsmallfocalelevationsattheretinasurface(Fig.3).ChoroidalabnormalitiesweredetectedintwoeyesoftwopatientswithEOS.Oneeyepresentedwithapalcoidchoroidalnoduleandtheothereyepresentedwithalocalizedreductioninchoroidalthicknessattheperifovealregion.Qualitativeabnormalitieswerenotobservedincontrolsubjects.TheSD-OCToffourretinalhamartomasinfoureyesrevealedtumorswithdifferentaspects.Inbotheyesofapatient,tumorshadahighlyinternallyreﬂectiveandtranslu-centmasswithcleardelineationoftheexternalretinallayersandRPE.TheseendophytictumorsseemtobeconﬁnedtotheRNFLandganglioncelllayer(Figs.4A,4B).TwohamartomasinanothertwopatientswereassociatedwithERMontheirsurfaceanddisplayedretinaldisorganizationofmultiplelayerswithdisruptionoftheellipsoidzone(Figs.4C,4D).Atthemacula,theellipsoidzonewaspreservedinalleyes,theVMAwaspresentinalleyes,andnoeyespresentedcystoidmacularedema(Table3).Itisinterestingtonotethatmostoftheﬁndingswerepresentinonlyoneeyefromeachpatient;withtheexceptionsofpatients7and8.TheﬁrstofthesepatientspresentedbilateralsubclinicalretinalhamartomasandsubtleERMwithundulationsoftheinnerretinalsurfaceandtheTABLE2.IncidenceofOcularSpeciﬁcFindingsinPatientsWithNeuroﬁbromatosisType2OcularFindingAll9PatientsEarlyOnset(n¼5)LateOnset(n¼4)EyesPatients%ofn¼9EyesPatients%ofn¼5EyesPatients%ofn¼4Cataract8555.563602250ERM7555.575100000Hamartoma4333.34360000Strabismus2222.22240000TABLE3.Spectral-DomainOpticalCoherenceTomography:FeaturesinNeuroﬁbromatosisType2EyesPatientsCMTTMVFlame-ShapedERMSubtleERMRNFLElevationRetinalHamartomaEZDVMA1-OD253lm8.57mm3     þ1-OS251lm8.75mm3  þ  þ2-OD261lm8.32mm3  þ  þ2-OS249lm8.33mm3     þ3-ODRDRDRDRDRDþRDRD3-OS267lm7.97mm3 þ   þ4-ODCATCATCATCATCATCATCATCAT4-OS555lm9.79mm3þ    þ5-OD443lm9.59mm3þ þ  þ5-OS332lm9.19mm3     þ6-OD286lm8.91mm3     þ6-OS284lm8.95mm3     þ7-OD283lm6.35mm3 þ þ þ7-OS320lm8.75mm3 þ þ þ8-OD364lm9.44mm3þ    þ8-OS257lm8.41mm3þ  þþþ9-OD291lm8.77mm3     þ9-OS275lm8.53mm3     þVMA,vitreomacularadhesion;CME,cystoidmaculaedema;RD,retinaldetachment;CAT,cataract.SD-OCTFindingsinNeurofibromatosisType2IOVSjSpecialIssuejVol.57jNo.9jOCT264Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935468/ on 06/25/2017secondpatientwasobservedtohavebilateralﬂame-shapedERM.DISCUSSIONNeuroﬁbromatosis2isararediseasewithalifelongpotentialforunpredictabletumorgrowth.Earlydiagnosisandcompre-hensivefollow-uparechallenging.MostoftheophthalmicﬁndingsinNF2areprobablycongenital,buttheymaybecomesymptomaticovertime.15,27OcularNF2-speciﬁcﬁndingsusuallyappearbeforeneurologicalsymptomsandhearingloss;therefore,theyareextremelyusefulinearlydiagnosis,allowingforbetterplanningoftherapyinyoungpatientswithNF2.27–29SD-OCTscansrevealedretinalabnormalitiesinsevenofninepatientswithNF2.AllpatientswithretinalabnormalitiesonSD-OCThadbilateralvestibularschwannomas.Itispossiblethatthetwopatientswithunilateralvestibularschwannomaandwithoutretinaabnormalitiesweremosaics,whichoccursinapproximately25%ofNF2patients.13,14IncreaseinCMTfoundinEOSgroupwasprobablyduetotractioneffectsoftheERMinthreepatients.OnepatientwithEOSpresentedaperifovealhamartomathatcausedfovealdeformationandincreasedinCMTinbotheyes.Commonfeaturesamongourpatientsincludedﬂame-shapedERM,retinalundulationswithasubtleERM,focalelevationsofRNFL,andretinalhamartomas.Twoofourpatient’slesionsweresubclinicalretinalhamarto-masthatwereonlydetectedbySD-OCTscans.Theﬂame-shapedappearanceonOCTscansofERMinfoureyesofthreepatientswithanearlyonsetofNF2weresufﬁcientlydistinct,allowingtheestablishmentofapattern.Scheﬂeretal.26describedtheOCTcharacteristicsofapeculiarERMinthreeNF2patientswithaseverephenotype.Inoneofthecasesdescribed,theuniqueOCTﬁndingswerethesolereasonsthediagnosisofNF2wasestablished.McLaughlinetal.30describedocularhistopathologicﬁnd-ingsina32-year-oldwomanwhodiedfromNF2complications.TheyfoundathinERMintherighteyeconsistingofspindledandcuboidalcells,consistentwithaglialorigin.Inthelefteye,theyfoundathickERMconsistingofcordsthatarepredominantlycuboidalcells,whichareconsistentwithM¨ullercellsandanastrocyteorigin.Hanetal.31describedthehistologicfeaturesofanERMthatwassurgicallyremovedina2-year-oldchild.TheyfoundahighlycellularmembranewithuptofourlayersofcellsofindeterminateoriginandspeculatedFIGURE1.(A)SD-OCToftherighteyeofpatient8showinganERMwithﬂame-shapedappearanceextendingtothevitreous.ThereismilddisorganizationoftheinternalretinallayersandvitreouspartialdetachmentwithVMA.(B)SD-OCTofthelefteyeshowingaﬂame-shapedERMwithpreservationoftheretinalcontourandmicroarchitecture.(C)SD-OCTofthelefteyeofcase4showingaseveral-layerERMextendingintothevitreousandevidentretinalthickeningwithpreservationoftheellipsoidzone.(D)SD-OCTdemonstratingathickERMwithaﬂameshapeappearanceextendingintothevitreous,whichissimilartocase4.Therearefoldsontheretinasurfaceandmarkedretinalthickening.Theellipsoidzoneispreserved.FIGURE2.(A)SD-OCTofthelefteyeofpatient3showingﬁneundulationsontheretinalsurface,withpreservationoftheretinalmicroarchitectureandwithasubtleERM.(B)SD-OCTofthelefteyeofpatient7showingspeculatedundulationsoftheretinasurfacewithoutanevidentERM.Theellipsoidzoneispreserved.(C)SD-OCToftherighteyeofpatient7showingﬁneundulationsoftheretinalsurface,similartopatient3.SD-OCTFindingsinNeurofibromatosisType2IOVSjSpecialIssuejVol.57jNo.9jOCT265Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935468/ on 06/25/2017thattheNF2ERMishamartomatousinorigin.Chanetal.32describedthehistopathologicandimmunohistochemistryﬁndingsofsevenNF2eyes,andtheyfoundERMandretinalhamartomasinalleyes.TheyalsofoundretinaltuftsarisingfromRNFLinfoureyesofthreepatients.Someofourpatient’simagesshowremarkablesimilaritytotheRNFLtuftsfoundinhistopathologicsectionsofNF2eyesthatwerepreviouslydescribedbyChan.Tothebestofourknowledge,thisistheﬁrstdescriptionofSD-OCTfeaturesofsuchlesions.EpiretinalmembranesassociatedwithNF2maybedirectlyrelatedtodysplasicM¨ullercells.M¨ullercellsarethepredominantglialelementoftheretina.TheyprovidethemechanicalsupporttotheretinaandproducethebasementmembranematerialthatformstheILM.ExperimentalmodelsofculturedsensoryretinasuggestthatM¨ullercellsmightcontributetothedevelopmentofacellularmembraneincaseofILMdisruption.33Owingtotheabnormaladherensjunctions,M¨ullercellsthathavelosttheirwild-typeNF2allelemaynotbeabletoelongateandestablishradialpolarity,leadingtoepiretinalaccumulation.31M¨ullercells,liketheothermaincelltypesaffectedinNF2,areglialcellswithepithelialfeatures,suggestingthatthissubsetofglialcellsisparticularlysensitivetoNF2loss.Neuroﬁbromatosis2hamartomasresultfrommutationsinthecytoskeletalproteinencodedinthelongarmofchromosome22,whichfunctionsasatumorsuppressor.34IthasbeensuggestedthatNF2-ERMandretinalhamartomasrepresentdifferentaspectsofthesamepatholog-icalprocess.32ItispossiblethattheretinaltuftsandundulationsoftheretinalsurfacefoundinsomeofourpatientsarealsorelatedtodysplasicM¨ullercells.Inconclusion,ourstudyshowedthatSD-OCTdepictedretinaandvitreousalterationsinmostpatientswithNF2,anditisavaluabletoolforevaluatingthesepatients.EpiretinalmembranesandsubclinicalhamartomasthatareevidentonSD-OCTcanbedifﬁculttoidentifywiththefundusexam.EpiretinalmembraneinNF2hasuniquefeaturesthatdistinguishitfromidiopathicERMormembranesassociatedwithotherdiseases.Therefore,thedetectionofthispeculiarERMinayoungpatientisverysuggestiveofNF2.TheNF2diagnosticcriteriamaybeabsentattheinitialclinicalpresentationinchildren,anditisprobablythemainreasonforthedelayeddiagnosisintheNF2EOSgroup.Althoughthispaperreportsasmallnumberofpatientsﬂame-shapedERMappearstobespeciﬁcforNF2,anditsinclusionintheclassicaldiagnosticcriteriacouldbeveryuseful.FIGURE3.(A)SD-OCTofcase2showingdisruptionofILMwithafocalelevationofRNFLandpreservationofretinalmicroarchitecture.(B)SD-OCTofcase1showingsmallfocalelevationsatthelefteyefovea.Thefovealcontourandellipsoidzonearepreserved.(C)SD-OCTofcase5showingasmallfocalelevationofRNFLsimilartocases2and1.FIGURE4.(A)SD-OCTofthelefteyeofpatient7,showingaretinalhamartomainvolvingtheRNFLandganglionlayer.Externallayersandellipsoidzonearepreserved.(B)SD-OCToftherighteyeofpatient7showingaretinalhamartomathatissimilartotheoneinthefelloweye.(C)SD-OCTofaretinalhamartomawithanERMassociatedwithadetachedretinaofpatient3.(D)SD-OCTofthelefteyeofpatient8,showingaretinalhamartomawithdisorganizationoftheinternalandexternalretinallayers,whichisassociatedwithERManddisruptionoftheellipsoidzone.SD-OCTFindingsinNeurofibromatosisType2IOVSjSpecialIssuejVol.57jNo.9jOCT266Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935468/ on 06/25/2017AcknowledgmentsSupportedbyFederalUniversityofMinasGerais–Brazil(BeloHorizonte,MG,Brazil)andINCTdeMedicinaMolecular,CNPq/FAPEMIG/CAPES(BeloHorizonte,MG,Brazil).Disclosure:V.Waisberg,None;L.O.C.Rodrigues,None;M.B.Nehemy,None;M.Frasson,None;D.M.deMiranda,NoneReferences1.NIHconferencestatement.Neuroﬁbromatosis1(vonReck-linghausendisease)andneuroﬁbromatosis2(bilateralacousticneuroﬁbromatosis).AnnInternMed.1990;113:39–52.2.SeizingerBR,RouleauGA,OzeliusLJ,etal.GeneticlinkageofvonRecklinghausenneuroﬁbromatosistothenervegrowthfactorreceptorgene.Cell.1987;49:589–594.3.RoleauG,SeizingerBR,OzeliusLG,etal.GeneticlinkageanalysisofbilateralacousticneuroﬁbromatosistoaDNAmarkeronchromosome22.Nature.1987;329:246–248.4.CooperJ,GiancottiFG.MolecularinsightsintoNF2/Merlintumorsuppressorfunction.FEBSLett.2014;16:2743–2752.5.RodriguesLO,BatistaPB,Goloni-BertolloEM,etal.Neuroﬁ-bromatosispart1–diagnosisanddifferentialdiagnosis.ArqNeuropsiquiatr.2014;72:241–250.6.EvansDGR.Neuriﬁbromatosistype2(NF2):aclinicalandmolecularreview.OrphanetJRareDis.2009;4:16.7.EvansDG,HusonSM,DonnaiD,etal.Aclinicalstudyoftype2neuroﬁbromatosis.QJMed.1992;84:603–618.8.EvansDG,HowardE,GiblinC,etal.Birthincidenceandprevalenceoftumor-pronesyndromes:estimatesfromaUKfamilygeneticregisterservice.AmJMedGenet.2010;152A:327–332.9.AntinheimoJ,SankilaR,Carp´enO,PukkalaE,SainioM,J¨a¨askel¨ainenJ.Population-basedanalysisofsporadicandtype2neuroﬁbromatosis-associatedmeningiomasandschwanno-mas.Neurology.2000;54:71–76.10.ParryDM,EldridgeR,Kaiser-KupferMI,etal.Neuroﬁbroma-tosis2(NF):clinicalcharacteristicsof63affectedindividualandclinicalevidenceforheterogeneity.AmJMedGenet.1994;52:450–461.11.EldridgeR,ParryDM,Kaiser-KupferMI.Neuroﬁbromatosis2:clinicalheterogeneityandnaturalhistoryin39individualin9familiesand16sporadiccases.AmJHumGenetSuppl.1991;49:A676.12.GardnerWJ,FrazierCH.Bilateralacousticneuroﬁbromatosis:aclinicalstudyandﬁeldsurveyofafamilyofﬁvegenerationswithbilateraldeafnessinthirty-eightmembers.ArchNeurolPsychiatry.1930;23:266–302.13.KluweL,MautnerV,HeinrichB,etal.Molecularstudyoffrequencyofmosaicisminneuroﬁbromatosis2patientswithbilateralvestibularschwannomas.JMedGenet.2003;40:109–114.14.KluweL,MautnerVF.Mosaicisminsporadicneuroﬁbromato-sis2patients.HumMolGenet.1998;7:2051–2055.15.KayeLD,RothnerAD,BeauchampGR,MeyersSM,EstesML.OcularﬁndingsassociatedwithneuroﬁbromatosistypeII.Ophthalmology.1992;99:1424–1429.16.BoschMM,BoltshauserE,HarpesP,LandauK.Ophthalmo-logicﬁndingsandalong-termcourseinpatientswithneuroﬁbromatosistype2.AmJOphthalmol.2006;141:1068–1077.17.FeuchtM,GrifﬁthsB,Niem¨ullerI,HaaseW,RichardG,MautnerVF.Neuroﬁbroamtosis2leadstohigherincidenceofstrabismologicalandneuro-ophthalmologicaldisorders.ActaOphthalmol.2008;86:882–886.18.ViolaF,VillaniE,NatacciF,etal.Choroidalabnormalitiesdetectedbynear-infraredreﬂectanceimagingasanewdiagnosticcriterionforneuroﬁbromatosis1.Ophthalmology.2012;119:369–375.19.AbdolrahimzadehS,FelliL,PlaterotiR,etal.Morphologicandvasculaturefeaturesofthechoroidandassociatedchoroid-retinalthicknessalterationsinneuroﬁbromatosistype1.BrJOphthalmol.2015;99:789–793.20.ChangL,EI-DairiMA,FrempongTA,etal.Opticalcoherencetomographyintheevaluationofneuroﬁbromatosistype1subjectswithopticpathwaygliomas.JAAPOS.2010;14:511–517.21.Topcu-YilmazP,KasimB,KiratliH.Investigationofretinalnerveﬁberlayerthicknessinpatientswithneuroﬁbromatosis1.JpnJOphthalmol.2014;88:172–176.22.LandauK,YasargilGM.Ocularfundusinneuroﬁbromatosistype2.BrJOphthalmol.1993;77:646–649.23.MeyersSM,GutmanFA,KayeLD,RothnerAD.Retinalchangesassociatedwithneuroﬁbromatosis2.TransAmOphthalmolSoc.1995;93:245–257.24.FeuchtM,KluweL,MautnerVF,RichardG.Correlationofnonsenseandframeshiftmutationswithseverityofretinalabnormalitiesinneuroﬁbromatosis2.ArchOphthalmol.2008;126:1376–1380.25.SiskRA,BerrocalAM,ScheﬂerAC,DubovySR,BauerMS.Epirretinalmembranesindicateaseverephenotypeofneuroﬁbromatosistype2.Retina.2010;30:51–58.26.ScheﬂerAC,DubovySR,BerrocalAM.Opticalcoherencetomographycharacteristicsofepiretinalmembranesinneuro-ﬁbromatosisi2.OphthalmicSurgLasersImaging.2008;39:73–77.27.ParryDM,MacCollinMM,Kaiser-KupferMI,etal.Germ-linemutationsintheneuroﬁbromatosis2gene:correlationswithdiseaseseverityandretinalabnormalities.AmJHumGenet.1996;59:529–539.28.EvansDGR,BirchJM,RamsdenRT.Paediatricpresentationoftype2neuroﬁbromatosis.ArchDisChild.1999;81:496–499.29.ParryA,GianniniC,RaghavanR,etal.AggressivephenotypicandgenotypicfeaturesinpediatricandNF2-associatedmeningiomas:aclinicopathologicstudyof53cases.JNeuro-patholExpNeurol.2001;60:994–1003.30.McLaughlinME,PepinSM,MacCollinMM,ChoopongP,LessellS.Ocularpathologicﬁndingsofneuroﬁbromatosistype2.ArchOphthalmol.2007;125:389–394.31.HanDP,ChinM,SimonsKB,AlbertDM.Surgicalremovalofanatypicalmacularepiretinalmembraneinneuroﬁbromatosistype2:clinicopathologiccorrelationandvisualoutcome.ArchOphthalmol.2012;130:1337–1339.32.ChanC,KochCA,Kaiser-KupferMI,etal.Lossofheterozy-gosityfortheNFgeneinretinalandopticnervelesionsofpatientswithneuroﬁbromatosis2.JPathol.2002;198:14–20.33.SongBJ,KoMK,ChoeJK.UltrastructuralchangeoftheM¨ullercellinthecultureofsensoryretina.KoreanJOphthalmol.1995;9:84–88.34.SchachatAP,ShieldsJA,FineSL,etal.Combinedhamartomasoftheretinaandretinalpigmentepithelium.Ophthalmology.1984;91:1609–1615.SD-OCTFindingsinNeurofibromatosisType2IOVSjSpecialIssuejVol.57jNo.9jOCT267Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935468/ on 06/25/2017